12/09/2015
https://www.congress.gov...
"This kind of second class status is not how our government is supposed to work and it has real implications."
"Congress needs to take action on this to make sure that this market functions for patients."
"With great power comes great responsibility, but that responsibility is missing across the drug industry."
"Well, the question we are asking here is whether or not it is ethical to price the way you have priced."